Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 4808 to 4857 of 6456 in total
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2404\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
oxysterols receptor lxr-beta (liver x receptor beta) (nuclear orphan receptor lxr-beta) (ubiquitously-expressed nuclear receptor) (nuclear receptor ner). [source:swissprot;acc:p55055]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.984\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.784\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2405\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
thioredoxin interacting protein; upregulated by 1,25-dihydroxyvitamin d-3. [source:refseq;acc:nm\_006472]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.677\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
222.489\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00366\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
upf0183 protein. [source:swissprot;acc:q9bsu1]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.2\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
218.984\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
0.784\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2406\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
antithrombin-iii precursor (atiii) (pro0309). [source:swissprot;acc:p01008]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
signal transducing adaptor molecule 2; stam-like protein containing sh3 and itam domains 2. [source:refseq;acc:nm\_005843]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
182.563\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
183.232\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00366\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2407\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit beta type 3 (ec 3.4.25.1) (proteasome theta chain) (proteasome chain 13) (proteasome component c10-ii). [source:swissprot;acc:p49720]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
214.234\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.456\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00364\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor eif-2b alpha subunit (eif-2b gdp-gtp exchange factor). [source:swissprot;acc:q14232]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.984\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.784\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2408\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj570f3.6 (novel protein similar to lysophospholipase ii (lypla2)). [source:sptrembl;acc:q9uge0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
194.407\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
193.706\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00362\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
squamous cell carcinoma antigen 1 (scca-1) (protein t4-a). [source:swissprot;acc:p29508]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.984\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.784\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2409\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lactoylglutathione lyase (ec 4.4.1.5) (methylglyoxalase) (aldoketomutase) (glyoxalase i) (glx i) (ketone-aldehyde mutase) (s-d-lactoylglutathione methylglyoxal lyase). [source:swissprot;acc:q04760]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
194.407\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
193.706\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00362\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
oxysterols receptor lxr-alpha (liver x receptor alpha) (nuclear orphan receptor lxr-alpha). [source:swissprot;acc:q13133]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.984\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.784\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2410\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lysophospholipase i; lysophospholipase 1; lysophospholipid-specific lysophospholipase; acyl-protein thioesterase-1. [source:refseq;acc:nm\_006330]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
194.407\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
193.706\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00362\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit beta type 3 (ec 3.4.25.1) (proteasome theta chain) (proteasome chain 13) (proteasome component c10-ii). [source:swissprot;acc:p49720]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.234\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.456\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.778\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2411\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
epsin 1; eh domain-binding mitotic phosphoprotein. [source:refseq;acc:nm\_013333]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
217.873\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.644\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.771\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mawd binding protein (unknown protein 32 from 2d-page of liver tissue). [source:swissprot;acc:p30039]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
194.407\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
193.706\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00362\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2412\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lysophospholipase ii; acyl-protein thioesterase. [source:refseq;acc:nm\_007260]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mesoderm induction early response 1. [source:refseq;acc:nm\_020948]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.374\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
211.618\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
0.756\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2413\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit alpha type 3 (ec 3.4.25.1) (proteasome component c8) (macropain subunit c8) (multicatalytic endopeptidase complex subunit c8). [source:swissprot;acc:p25788]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serpin b12. [source:swissprot;acc:q96p63]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.984\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00359\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2414\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanylate kinase (ec 2.7.4.8) (gmp kinase). [source:swissprot;acc:q16774]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.361\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.116\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.755\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
megsin (tp55) (serpin b7). [source:swissprot;acc:o75635]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.984\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00359\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2415\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
elongation factor 1-alpha 1 (ef-1-alpha-1) (elongation factor 1 a-1) (eef1a-1) (elongation factor tu) (ef-tu). [source:swissprot;acc:p04720]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.366\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.117\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.751\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hurpin (hacat uv-repressible serpin) (protease inhibitor 13) (headpin) (serpin b13). [source:swissprot;acc:q9uiv8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.2\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
218.984\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00359\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2416\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
oxysterols receptor lxr-beta (liver x receptor beta) (nuclear orphan receptor lxr-beta) (ubiquitously-expressed nuclear receptor) (nuclear receptor ner). [source:swissprot;acc:p55055]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc-finger protein zpr1 (zinc finger protein 259). [source:swissprot;acc:o75312]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
217.366\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
218.117\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
0.751\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2417\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
elongation factor 1-alpha 2 (ef-1-alpha-2) (elongation factor 1 a-2) (eef1a-2) (statin s1). [source:swissprot;acc:q05639]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
upf0183 protein. [source:swissprot;acc:q9bsu1]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.2\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
218.984\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00359\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2418\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
antithrombin-iii precursor (atiii) (pro0309). [source:swissprot;acc:p01008]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
apoptosis-inducing factor (aif)-homologous mitochondrion-associated inducer of death; p53-responsive gene 3. [source:refseq;acc:nm\_032797]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.205\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.454\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.751\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2419\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 6 (26s proteasome regulatory subunit s10) (p42a) (proteasome regulatory particle subunit p44s10). [source:swissprot;acc:q15008]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
215.807\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.556\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.749\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor eif-2b alpha subunit (eif-2b gdp-gtp exchange factor). [source:swissprot;acc:q14232]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.984\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00359\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2420\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit alpha type 2 (ec 3.4.25.1) (proteasome component c3) (macropain subunit c3) (multicatalytic endopeptidase complex subunit c3). [source:swissprot;acc:p25787]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.048\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.748\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
squamous cell carcinoma antigen 1 (scca-1) (protein t4-a). [source:swissprot;acc:p29508]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.984\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00359\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2421\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
14-3-3 protein beta/alpha (protein kinase c inhibitor protein-1) (kcip-1) (protein 1054). [source:swissprot;acc:p31946]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.681\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.425\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.744\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
apoptosis-inducing factor (aif)-homologous mitochondrion-associated inducer of death; p53-responsive gene 3. [source:refseq;acc:nm\_032797]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.205\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.454\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00359\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2422\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
methylenetetrahydrofolate reductase (ec 1.5.1.20). [source:swissprot;acc:p42898]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.021\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.286\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.735\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
oxysterols receptor lxr-alpha (liver x receptor alpha) (nuclear orphan receptor lxr-alpha). [source:swissprot;acc:q13133]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.984\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00359\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2423\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 3 (26s proteasome regulatory subunit s3) (proteasome subunit p58). [source:swissprot;acc:o43242]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.645\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.376\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.731\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
histone deacetylase 5 (hd5) (antigen ny-co-9). [source:swissprot;acc:q9uql6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.682\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.471\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00358\vspace{3pt}}}\\\cline{1-2}\cline{5-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2424\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone deacetylase 4 (hd4). [source:swissprot;acc:p56524]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
221.472\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit alpha type 4 (ec 3.4.25.1) (proteasome component c9) (macropain subunit c9) (multicatalytic endopeptidase complex subunit c9) (proteasome subunit l). [source:swissprot;acc:p25789]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.049\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.323\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.726\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2425\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone deacetylase 9 (hd9) (hd7b) (hd7). [source:swissprot;acc:q9ukv0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.682\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.472\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00358\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pepsin a precursor (ec 3.4.23.1). [source:swissprot;acc:p00790]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
235.812\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.088\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.724\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2426\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mesoderm induction early response 1. [source:refseq;acc:nm\_020948]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.374\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.618\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00357\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 20 (phosphate transporter), member 2; glvr-2; pit-2; gibbon ape leukemia virus receptor 2; murine leukemia virus, amphotropic; receptor. [source:refseq;acc:nm\_006749]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
235.812\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
235.088\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
0.724\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2427\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
farnesyl pyrophosphate synthetase (fpp synthetase) (fps) (farnesyl diphosphate synthetase) [includes: dimethylallyltransferase (ec 2.5.1.1); geranyltranstransferase (ec 2.5.1.10)]. [source:swissprot;acc:p14324]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit alpha type 3 (ec 3.4.25.1) (proteasome component c8) (macropain subunit c8) (multicatalytic endopeptidase complex subunit c8). [source:swissprot;acc:p25788]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.374\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.618\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00357\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2428\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alcohol dehydrogenase class iii chi chain (ec 1.1.1.1) (glutathione- dependent formaldehyde dehydrogenase) (ec 1.2.1.1) (fdh). [source:swissprot;acc:p11766]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
192.871\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
193.555\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00355\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protocadherin 15 precursor. [source:swissprot;acc:q96qu1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
235.812\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.088\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.724\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2429\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
esterase d (ec 3.1.1.1). [source:swissprot;acc:p10768]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
192.871\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
193.555\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00355\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/